or Try an Advanced Search...

    Treatment Of Parkinson's Disease Stocks List

    Symbol Grade Name % Change
    ITCI C Intra-Cellular Therapies Inc. -0.22
    NRSNW C NeuroSense Therapeutics Ltd. - warrant 55.82
    IKT C Inhibikase Therapeutics, Inc. 1.52
    AMRX C Amneal Pharmaceuticals, Inc. -1.07
    TEVA C Teva Pharmaceutical Industries 0.29
    ACAD C ACADIA Pharmaceuticals Inc. -0.55
    ATHE F Alterity Therapeutics Limited 1.90
    CCM F Concord Medical Services Holdings Limited ADS 5.95
    NERV F Minerva Neurosciences, Inc 4.25
    VYGR F Voyager Therapeutics, Inc. 1.31
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Care
    Related Stock Lists: Parkinson's Disease Alzheimer's Disease Medicine Drugs Neuroscience Schizophrenia Aging Associated Diseases Amyotrophic Lateral Sclerosis Biopharmaceutical Biotechnology Cancer Dementia Depressive Disorder Huntington's Disease Insomnia Major Depressive Disorder Medication Neurological Disorders Pain Pharmaceutical

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Parkinson's Disease stocks.

    Symbol Grade Name Weight
    MNTL D Tema Neuroscience and Mental Health ETF 8.74
    ISRA A Market Vectors Israel ETF 8.64
    FBT D First Trust Amex Biotech Index Fund 7.75
    XPH B SPDR S&P Pharmaceuticals ETF 5.34
    PSIL C AdvisorShares Psychedelics ETF 4.94
    View all Treatment Of Parkinson's Disease ETFs...
    Compare ETFs
    Compare FBT to XPH Compare ISRA to XPH Compare MNTL to ISRA

        Treatment Of Parkinson's Disease Stocks Recent News

        Date Stock Title
        Nov 21 AMRX Amneal gets FDA approval for generic Byetta, resubmits DHE NDA
        Nov 21 AMRX Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist
        Nov 21 NRSNW NeuroSense Therapeutics to Participate in the 2024 International Symposium on ALS/MND
        Nov 21 TEVA Teva Pharmaceutical (TEVA): The Global Leader in Affordable Medicine Under $25
        Nov 20 VYGR Voyager selects gene therapy development candidate for Alzheimer’s disease
        Nov 20 VYGR Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease
        Nov 19 TEVA Teva Pharmaceutical Industries Limited (TEVA) Jefferies London Healthcare Conference (Transcript)
        Nov 19 ITCI Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
        Nov 18 IKT Inhibikase Therapeutics files for secondary offering of common stock
        Nov 18 VYGR Voyager Therapeutics' Tracer Platform Targets CNS Market: Here's Why I'm Neutral
        Nov 16 TEVA Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Care
        Related Stock Lists: Parkinson's Disease Alzheimer's Disease Medicine Drugs Neuroscience Schizophrenia Aging Associated Diseases Amyotrophic Lateral Sclerosis Biopharmaceutical Biotechnology Cancer Dementia Depressive Disorder Huntington's Disease Insomnia Major Depressive Disorder Medication Neurological Disorders Pain Pharmaceutical
        Treatment Of Parkinson's Disease

        Treatment of Parkinson's disease typically involves a combination of medications, lifestyle changes, and therapies. Medications used to treat Parkinson's disease include levodopa, dopamine agonists, MAO-B inhibitors, anticholinergics, and amantadine. Lifestyle changes may include exercise, diet, and stress management. Therapies such as physical therapy, occupational therapy, speech therapy, and cognitive behavioral therapy may also be used to help manage symptoms.

        Browse All Tags